clofibrate has been researched along with Diabetes Mellitus, Type 2 in 10 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clofibrate 1500 mg was administered for 1 month to 15 patients, and 75 g oral glucose tolerance test and insulin tolerance test were carried out before and after 1 month of the treatment." | 1.27 | Clofibrate enhances the affinity of insulin receptors in non-insulin dependent diabetes mellitus. ( Kobayashi, M; Koh, H; Murakami, K; Nambu, S; Shigeta, Y, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henke, BR | 1 |
| Abramson, J | 1 |
| Murakami, K | 1 |
| Nambu, S | 2 |
| Koh, H | 1 |
| Kobayashi, M | 2 |
| Shigeta, Y | 2 |
| Skrha, J | 1 |
| Sindelka, G | 1 |
| Haas, T | 1 |
| Hilgertová, J | 1 |
| Justová, V | 1 |
| Welborn, TA | 1 |
| Rajecová, E | 1 |
| Klimes, I | 1 |
| Seböková, E | 1 |
| Rychnavská, E | 1 |
| Pleváková, L | 1 |
| Linke-Cvrkalová, A | 1 |
| Langrová, H | 1 |
| Wang, MY | 1 |
| Koyama, K | 1 |
| Shimabukuro, M | 1 |
| Mangelsdorf, D | 1 |
| Newgard, CB | 1 |
| Unger, RH | 1 |
| Gómez Gómez, M | 1 |
| Valdivieso Martínez, B | 1 |
| Jaén Martínez, F | 1 |
| Hanefeld, M | 1 |
| Schulze, J | 1 |
| Fischer, S | 1 |
| Rössger, G | 1 |
| Lindner, J | 1 |
| Groh, G | 1 |
| Nehring, A | 1 |
| Capek, R | 1 |
| Hirata, Y | 1 |
| Omori, Y | 1 |
| Sakamoto, N | 1 |
| Baba, S | 1 |
2 reviews available for clofibrate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; M | 2004 |
Dyslipidaemia in non-insulin dependent diabetes: the need for a clinical intervention trial.
Topics: Cholesterol, HDL; Clinical Trials as Topic; Clofibrate; Coronary Disease; Diabetes Mellitus, Type 2; | 1994 |
2 trials available for clofibrate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Intensive basic therapy decreases the need for drug treatment and improves glucose control: an important result of the diabetes intervention study].
Topics: Clinical Trials as Topic; Clofibrate; Clofibric Acid; Combined Modality Therapy; Diabetes Mellitus, | 1988 |
Improvement of glucose tolerance in NIDDM by clofibrate. Randomized double-blind study.
Topics: Blood Glucose; Clinical Trials as Topic; Clofibrate; Diabetes Mellitus, Type 2; Double-Blind Method; | 1988 |
6 other studies available for clofibrate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Comments on the MRC/BHF Heart Protection Study.
Topics: Adult; Antihypertensive Agents; Cholesterol; Clofibrate; Coronary Disease; Cost-Benefit Analysis; Di | 2003 |
Clofibrate enhances the affinity of insulin receptors in non-insulin dependent diabetes mellitus.
Topics: Blood Glucose; Clofibrate; Diabetes Mellitus, Type 2; Erythrocytes; Female; Glucose Tolerance Test; | 1984 |
[Relation between hypertriacylglycerolemia and the action of insulin in type 2 diabetes mellitus].
Topics: Adult; Aged; Clofibrate; Diabetes Mellitus, Type 2; Female; Fenofibrate; Humans; Hypertriglyceridemi | 1994 |
[Etofylline clofibrate in the treatment of diabetic dyslipidemia: results of a 6-month period of therapy].
Topics: Clofibrate; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoprotei | 1995 |
Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
Topics: Animals; Base Sequence; Carrier Proteins; Clofibrate; Diabetes Mellitus, Type 2; DNA Primers; DNA-Bi | 1998 |
[Drug interactions in geriatrics. Apropos a case].
Topics: Aged; Clofibrate; Diabetes Mellitus, Type 2; Drug Synergism; Glyburide; Humans; Hypoglycemia; Male | 1989 |